Nurix Therapeutics Director Julia P. Gregory Reports Sale of Common Shares Worth $528,528.0154
Nurix Therapeutics director Julia P. Gregory sold 22,583 common shares at $23.4038 on Oct. 14, 2026, a Form 4 filing showed. Gregory exercised director stock options to acquire 22,583 common shares at $1.86 per share on the same date. Following the transactions, she directly owned 10,750 common shares, with none of the